Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Malaria

1-methyl-3-isobutylxanthine has been researched along with Malaria in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Malaria: A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Klotz, C1
Frevert, U1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Malaria

ArticleYear
Plasmodium yoelii sporozoites modulate cytokine profile and induce apoptosis in murine Kupffer cells.
    International journal for parasitology, 2008, Volume: 38, Issue:14

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Apoptosis; Bucladesine; Cytokines; Host-Parasite Interactions;

2008